A previous structure–activity relationships (SARs) study showed that an increase in the lipophilicity of arylalkyl ITCs by incorporating an aromatic ring is one of the key structural features important for their potency to deplete mutant p53 and induce apoptosis in human cancer cells [22]. This evidence concerns the gene TP53 and cancer.